AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Allocating to a wide market index fund for retirement aims to spread risk across the market, supporting steady growth while keeping fees reasonable.
28,235 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
SERHANT. launches in four major Texas markets with 13 founding agents and six independent brokerages, aiming to accel...
Moderna led a broad vaccine stock rally, rising about 14% as investors priced in pipeline momentum and favorable regu...
As humanoid robots scale from labs to factories, two equipment makers rise as the hidden winners in the trillion-doll...
AMD and Marvell released quarterly results centered on AI infrastructure, highlighting different strategic bets in da...
Figure Technology Solutions stock captured attention with a double‑digit jump in a shortened week. This article break...
Meta’s legal exposure has surged to roughly $1.4 trillion ahead of a high-stakes August 2026 trial, testing how inves...
Tom Zschach, who led SWIFT's digital asset strategy for six years, publicly dismissed XRP partnership rumors on July ...
Thailand's central bank has flagged unusual stablecoin transfers as part of a broader crackdown on the grey economy. ...
AI-driven capex is lifting lithography demand, placing ASML at the center of a multiyear upgrade cycle. This piece ex...
Jay Papasan is stepping down from Keller Williams after more than two decades shaping the company’s content strategy....
XRP starts the week trading around $1.52 as it tests critical levels near $1.60 and $1.40, with volatility mounting a...